Ryan Confer Discusses Genprex’s Future in Diabetes and Oncology
In an in-depth conversation with Ryan Confer, CEO of Genprex (GNPX), we explored the company’s dynamic pipeline, including…
Short Squeeze: Riding MRNA’s Downfall to $25
This article is brought to you by Marathon Money Plus. Let’s cut to the chase: Moderna’s been on…